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Objectives
To define Patient Acceptable Symptom State (PASS) thresholds for the Oxford hip score 
(OHS) and Oxford knee score (OKS) at mid-term follow-up.
Methods
In a prospective multicentre cohort study, OHS and OKS were collected at a mean follow-up 
of three years (1.5 to 6.0), combined with a numeric rating scale (NRS) for satisfaction and 
an external validation question assessing the patient’s willingness to undergo surgery again. 
A total of 550 patients underwent total hip replacement (THR) and 367 underwent total 
knee replacement (TKR).
Results
Receiver operating characteristic (ROC) curves identified a PASS threshold of 42 for the OHS 
after THR and 37 for the OKS after TKR. THR patients with an OHS ≥ 42 and TKR patients with 
an OKS ≥ 37 had a higher NRS for satisfaction and a greater likelihood of being willing to 
undergo surgery again.
Conclusions
PASS thresholds appear larger at mid-term follow-up than at six months after surgery. With- 
out external validation, we would advise against using these PASS thresholds as absolute 
thresholds in defining whether or not a patient has attained an acceptable symptom state 
after THR or TKR.
Cite this article: Bone Joint Res 2014;3:7–13.
Article focus
 Patient Acceptable Symptom State (PASS)
thresholds define whether a patient has
achieved an acceptable level of function-
ing after an intervention, such as hip or
knee replacement
 Contrary to Minimal Clinically Important
Differences, in PASS the outcome is of
interest, instead of the extent of improve-
ment
Key messages
 PASS thresholds are time-dependent
 External criteria, such as a numerical rat-
ing scale for satisfaction or validation
questions, which have been shown to be
related to patient satisfaction after joint
replacement, can be employed to vali-
date PASS thresholds
Strengths and limitations
 The main strength of our study is the val-
idation of the PASS thresholds using two
different external criteria
 The main weakness of our study is the
absence of a pre-operative measurement
of the Oxford hip (OHS) and knee scores
(OKS)
Introduction
Several distinct types of outcome measures
are of interest in orthopaedic surgery. The
time to a certain event, such as revision sur-
gery, has historically been the principal
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outcome of interest in joint replacement patients.1,2 In
recent years, patient-reported outcome measures
(PROMs) have become popular, allowing the assessment
of the clinical outcome of joint replacement from the
patient’s perspective.3 PROMs can be summarised in
numerous ways. In the orthopaedic literature, mean
scores of the study population are frequently presented.
The mean pre-operative score provides information on
the ‘average’ patient before surgery. Similarly, the mean
post-operative score provides information on the ‘aver-
age’ patient after surgery, and the mean change in these
scores provides information on the improvement (or
deterioration) experienced by the ‘average’ patient, who
does improve substantially after joint replacement.4
However, a large proportion of joint replacement
patients suffer from persisting pain, or are dissatisfied
with the surgical results.5-7 Data regarding the mean
improvement after joint replacement mainly report the
improvement of many patients with successful out-
comes, but can neglect patients with suboptimal out-
comes, making it of limited use for individual patients
encountered in clinical practice.
Patient Acceptable Symptom States (PASS) and Mini-
mal Clinically Important Differences (MCIDs) are two
complementary constructs, which allow a more individu-
alised approach to the analysis of PROMs.8-10 PASS is
defined as an outcome score threshold of the post-opera-
tive score, above which a patient is defined as experienc-
ing a satisfactory outcome, and below which an
unsatisfactory outcome is experienced. MCID is defined
as the minimum amount of improvement between pre-
and post-operative scores that a patient should experi-
ence after a specific intervention in order to have achieved
a minimally important difference. PASSs and MCIDs allow
estimation of the probability of a satisfactory outcome or
a relevant improvement. These probabilities are relevant
for individual patients, encountered in clinical practice,
who either do or do not achieve an acceptable state or
experience a relevant improvement.11 
Recently, PASSs have been estimated for the Oxford hip
score (OHS)12 and Oxford knee score (OKS)13 at short-
term follow-up.14 An important issue is whether the cho-
sen follow-up period of six months after joint replace-
ment is adequate. A recent systematic review has
suggested that patients may not have fully recovered at
six months after THR.15 Thresholds that define whether or
not patients have achieved an acceptable symptom state,
such as the PASS, may therefore differ between patients
who are still recovering from their surgery and patients
who have recovered fully. Therefore, we questioned
whether PASS thresholds are different at mid-term com-
pared with short-term follow-up. We questioned whether
the OHS and OKS are correlated to patient satisfaction at
mid-term follow-up. Additionally, we questioned
whether responders (i.e., patients who have an accept-
able symptom state according to the PASS) are more
satisfied than non-responders. Finally, we questioned
whether responders were more likely to be willing to
undergo surgery again, compared with non-responders. 
Materials and Methods
The current study is part of a multicentre cohort study of
health-related quality of life (HRQoL) after THR/TKR
(NTR2190), performed from August 2010 to August
2011.16-20 Institutional Review Board approval was
obtained from all participating centres and all patients
gave written informed consent (CCMO-Nr:
NL29018.058.09; MEC-Nr: P09.189). It concerned the
clinical follow-up of a multi-centre randomised controlled
clinical trial, comparing the use of the drug erythropoie-
tin and two re-infusion techniques of autologous blood in
order to decrease allogenic blood transfusions (Nether-
lands Trial Register: NTR303). In this trial, 2442 primary
and revision hip or knee replacements in 2257 patients
were included between 2004 and 2009. All patients who
participated in the randomised controlled trial completed
pre-operative HRQoL questionnaires, underwent primary
THR or TKR and who were alive at the time of inclusion for
the present follow-up study, were eligible for inclusion.
The first joint replacement was selected for inclusion in
the follow-up study for patients who participated more
than once in the previous study. Records of the financial
administration of all participating centres were checked
in order to ascertain that all eligible patients were alive
before being approached by the first author (JCK). For the
present follow-up study, all eligible patients were first
sent an invitation letter signed by their treating orthopae-
dic surgeon, an information brochure and a reply card.
Patients who indicated that they were willing to partici-
pate were sent a questionnaire. Patients who did not
respond to the first invitation within four weeks were sent
another invitation letter. Those who did not respond to
this second invitation were contacted by telephone by
the first author. Patients who did not return their ques-
tionnaire within four weeks were also contacted by tele-
phone by the first author. The data used in this report
constitute a subset of patients who completed post-oper-
ative questionnaires.
Outcome measures. We measured the overall satisfaction
with the outcome of surgery on a numeric rating scale
(NRS), which ranged from 0 (extremely dissatisfied) to
10 (extremely satisfied).16,17 We added a validation ques-
tion to the questionnaire, which took the following form:
“Knowing what your hip or knee replacement surgery
did for you, would you still have undergone this sur-
gery?”, with dichotomous answers of ‘yes’ vs ‘no’. This
validation question was previously used in a similar vali-
dation study of clinically important differences after THR
and TKR.21
Joint-specific PROMs were measured using the OHS for
THR patients and the OKS for patients undergoing TKR,
both of which were translated and validated in Dutch.22,23
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Each questionnaire comprises 12 questions regarding
pain and functioning of the hip or knee during the previ-
ous four weeks. Each question is answered on a five-point
Likert scale, and an overall score is calculated by summa-
rising the responses to each of the 12 questions. This sum
score ranges from 0 to 48, where 0 indicates the most
severe symptoms and 48 the least severe symptoms.
Potential confounders included age at joint replace-
ment, gender, body mass index (BMI), indication for joint
replacement (osteoarthritis (OA) vs other), patient-
reported Charnley classification of comorbidity24,25
(A, patients in which the index operated hip or knee are
affected only; B, patients in which the other hip or knee is
affected as well; C, patients with a hip or knee replace-
ment and other affected joints and/or a medical condition
which affects the patients’ ability to ambulate) and pre-
operative HRQoL. HRQoL was measured pre-operatively
using the Short-Form (SF-)36,26 which is translated and
validated in the Dutch language.27 The 36 items cover
eight domains (physical function, role physical, bodily
pain, general health, vitality, social function, role emo-
tional, and mental health), for which a sub-scale score is
calculated (100 indicating no symptoms and 0 indicating
extreme symptoms). These sub-scales can be sum-
marised in a physical component summary (PCS) and a
mental component summary (MCS).
Statistical analysis. We performed descriptive analyses
of the patients’ baseline characteristics. All analyses were
performed separately for THR and TKR, as MCIDs have
been shown to differ considerably between these surgical
interventions.28 The correlation between OHS or OKS
and NRS for satisfaction was calculated using Pearson’s
correlation coefficient. Receiver operating characteristic
(ROC) curves were used to identify thresholds for OHS/
OKS scores at mid-term follow-up, which are associated
with an acceptable level of patient satisfaction with joint
replacement. An acceptable level of patient satisfaction
was defined as a NRS for satisfaction ≥ 5, which is the
equivalent of a visual analogue scale satisfaction score
≥ 50.3,29 This particular threshold has been used previ-
ously to compare satisfied and dissatisfied patients after
joint replacement.14 The chosen PASS thresholds were
equivalent to the point at which sensitivity and specificity
were closest.30 The 95% confidence intervals (CI) around
the thresholds were estimated using percentile bootstrap
methods, based on 1000 random samples with replace-
ment from the original data. In order to explore whether
the found thresholds are consistent across subgroups, we
identified separate thresholds for subgroups based on the
following variables: length of follow-up (< 3 years vs
≥ 3 years), gender, age (< 70 years vs ≥ 70 years), BMI
(< 30 kg/m2 vs ≥ 30 kg/m2), Charnley classification (A/B vs
C), SF-36 PCS (< 50 vs ≥ 50) and SF-36 MCS (< 50 vs ≥ 50).
Based on the overall PASS thresholds, we divided
patients into responders (those with an OHS or OKS ≥ the
PASS threshold) and non-responders (OHS/OKS < PASS
threshold). We compared the mean NRS for satisfaction
between responders and non-responders separately for
THR and TKR patients, using three different models. In the
first model, we calculated the mean NRS for satisfaction of
all responders and the mean NRS of all non-responders,
stratified by centre. In the second model, we performed
linear mixed model regression analyses, with age and
gender as fixed effects and the centre as a random effect,
while stratifying for quartile of follow-up length. The final
model consisted of linear mixed model regression analy-
ses, with age, gender, BMI, Charnley classification, indica-
tion (OA vs other), and pre-operative SF-36 PCS and MCS
as fixed effects and the centre as a random effect, while
stratifying for quartile of follow-up length.
Table I. Patient characteristics (THR, total hip replacement; TKR, total knee replacement)
Characteristic* Primary THR (n = 550) Primary TKR (n = 367
Mean follow-up (yrs) (SD; range) 3.2 (1.1; 1.5 to 6.0) 3.2 (1.1; 1.3 to 6.0)
Mean (SD) age at operation (yrs) 65.9 (10.5) 68.7 (9.6)
Male (n, %) 188 (34.2) 122 (33.3)
Body mass index group at follow-up (n, %)
< 25 kg/m2 182 (34.3)62 (17.9)
25 to 29 kg/m2 226 (42.6) 154 (44.5)
30 to 34 kg/m2 94 (17.7) 81 (23.4)
> 35 kg/m2 28 (5.8) 49 (14.2)
Indication for arthroplasty (n, %)
Osteoarthritis 471 (86.3) 323 (89.0)
Patient-reported Charnley classification at follow-up (n, %)
A 119 (23.1) 49 (13.9)
B 74 (14.3) 36 (10.2)
C 323 (62.6) 267 (75.9)
Median pre-operative SF-36 scores (IQR)
Physical component summary 39.8 (34.1 to 45.3) 41.3 (35.0 to 47.3)
Mental component summary 54.8 (45.6 to 60.0) 54.1 (45.4 to 59.1)
* SF-36, Short-Form 36; IQR, interquartile range
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Finally, we compared the odds of responding the vali-
dation question positively between responders and non-
responders, using three different models. In the first
model, we calculated crude odds ratios. In the second
model, we performed logistic mixed model regression
analyses, with age and gender as fixed effects and the
centre as a random effect, while stratifying for quartile of
follow-up length. In the final model, we performed logis-
tic mixed model regression analyses, with age, gender,
BMI, Charnley classification, indication (OA vs other), and
pre-operative SF-36 PCS and MCS as fixed effects and the
centre as a random effect, while stratifying for quartile of
follow-up length.
All analyses were performed using R v2.14.1.31 
Results
A total of 550 patients underwent THR and 367 under-
went TKR. Patient characteristics are described in Table I.
The mean follow-up was similar for THR and TKR patients,
at 3.2 years (1.5 to 6.0) and 3.2 years (1.3 to 6.0), respec-
tively. THR patients were slightly younger at joint replace-
ment surgery than TKR patients. The proportion of males
was similar. TKR were more often obese or morbidly
obese. The majority of THR and TKR patients underwent
joint replacement for primary OA.
The mean and median OHS scores at mid-term follow-
up were 41.5 (SD 7.93) and 44 (interquartile range (IQR)
39 to 47), respectively. The mean NRS for satisfaction was
8.55 (SD 2.19) and 94.7% (521 of 550) of all THR patients
were satisfied (defined as NRS ≥ 5). The mean and median
OKS scores at mid-term follow-up were 39.1 (SD 9.04)
and 42 (IQR 35 to 46), respectively. The mean NRS for sat-
isfaction was 8.07 (SD 2.61) and 90.7% (333 of 367) of all
TKR patients were satisfied.
The NRS correlated with both the OHS (Pearson corre-
lation coefficient 0.52 (95% CI 0.46 to 0.58)) and the OKS
(Pearson correlation coefficient 0.64 (95% CI 0.57 to
0.69)), indicating a large correlation.
ROC curves of OHS thresholds and OKS thresholds are
shown in Figures 1 and 2. The OHS ROC curve revealed a
PASS threshold of 42, with a sensitivity of 67.0% and a
specificity of 65.5%. The area under the ROC curve (AUC)
was 0.72 (95% CI 0.60 to 0.84). The OKS ROC curve
revealed a PASS threshold of 37, with a sensitivity of 76.3%
and a specificity of 76.5%. The AUC was 0.83 (95% CI 0.74
to 0.93). ROC curves of subgroups showed variation in the
thresholds found (Tables II and III). The variation appears
larger in OHS thresholds than in OKS thresholds.
The mean NRS for satisfaction was significantly higher
in responders than in non-responders, both for THR and
TKR (Table IV). Both models showed a mean difference
between responders and non-responders of approxi-
mately two points for THR patients and three points for
TKR patients. Responders were more likely to be willing to
undergo surgery again (Table V). All models showed odds
ratios of approximately 7, indicating a seven-times higher
odds of willingness to undergo surgery again in
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Fig. 1
Receiver operating characteristic (ROC) curve to establish a threshold for the
mid-term follow-up Oxford hip score associated with mid-term satisfaction
with surgery. Sensitivity (67.0%) and specificity (65.5%) are in equilibrium
when a threshold of 42 points is chosen. The area under ROC curve (AUC) was
0.72 (95% confidence interval 0.60 to 0.84).
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Fig. 2
Receiver operating characteristic (ROC) curve to establish a threshold for the
mid-term follow-up Oxford hip score associated with mid-term satisfaction
with surgery. Sensitivity (76.3%) and specificity (76.5%) are in equilibrium
when a threshold of 37 points is chosen. The area under ROC curve (AUC)
was 0.83 (95% confidence interval 0.74 to 0.93).
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responders versus non-responders, while controlling for
confounding (Table V).
Discussion
PASS thresholds for the OHS and OKS are considerably
higher at mid-term follow-up than those at six months
post-operatively. The multiple approaches in validating
the PASS thresholds and the rigorous efforts to minimise
confounding are the main strengths of this study. All
approaches show that the thresholds of 42 points for the
OHS and 37 points for the OKS can discriminate between
successful and less successful patient outcomes after THR
or TKR in this study population, according to the overall
satisfaction assessment and the willingness to undergo
surgery again.
A limitation of our study is that we did not measure the
OHS or OKS pre-operatively. Consequently, we could not
investigate whether the PASS thresholds are valid across
strata of baseline OHS or OKS scores. As a surrogate mea-
surement of pre-operative joint functioning, we investi-
gated differences in PASS thresholds in strata of the pre-
operative physical and mental component summaries of
the SF-36, which only had a small effect. Furthermore,
other evidence from the same research group suggests
that baseline OHS or OKS values are poor predictors of
overall patient satisfaction with the outcome of the joint
replacement.14,32
Another limitation of our study is the broad range in
follow-up length. In order to account for this range, we
stratified our analysis per quartile of follow-up period.
Although a residual effect of follow-up length cannot be
excluded, we do not think this is very plausible, as recent
evidence suggests that after full recovery has taken place,
the improvement in joint function is sustained through-
out mid-term follow-up.33
Demographically, our study population is similar to
that of Judge et al.14 Cultural differences cannot be
excluded from explaining the differences found in PASS
thresholds, although this is unlikely, given the resem-
blance of English and Dutch urban joint replacement
patients. A more plausible explanation could be the dif-
ference in physical recovery. Patients who are fully recov-
ered at mid-term follow-up could be less prone to be
satisfied with lower OHS or OKS scores, as the probability
of further improvement in physical functioning is small.
Six months after joint replacement, patients might be
more readily satisfied with suboptimal OHS or OKS
scores, as the speed of recovery is quite high.
Conceptually, MCIDs and PASSs are complementary.
Both approach an individual patient’s health state, but
from a slightly different angle. In MCIDs, the emphasis is
on whether or not an individual has improved after a cer-
tain therapy.34 In PASSs, the emphasis is on whether or
not the achieved outcome is acceptable from the patients
perspective.34 Both MCIDs and PASS have gained in inter-
est recently.28,35-37 PASS might be more important than
the MCID, as Dougados38 phrased eloquently: “It’s good
to feel better but it’s better to feel good.” Similar
Table II. Patient acceptable symptom state (PASS) score thresholds for
mid-term follow-up Oxford hip score and proportion of patients classi-
fied as reaching a satisfactory symptom state (CI, confidence interval)
Parameter*
Threshold value 
(95% CI)
Satisfactory symptom
state (n, %)
Entire population 42 (38.5 to 44.2) 359 (65.3)
Follow-up
< 3 years 45 (39.6 to 46.5) 134 (47.2)
≥ 3 years 39 (30.5 to 42.5) 184 (69.2)
Gender
Males 47 (44.2 to 47.5) 85 (45.2)
Females 38 (30.5 to 41.2) 258 (71.3)
Age
< 70 years 44 (39.1 to 45.5) 204 (60.0)
≥ 70 years 40 (30.5 to 42.5) 127 (60.5)
BMI
< 30 kg/m2 43 (39.6 to 45.5) 280 (68.6)
≥ 30 kg/m2 36 (25.5 to 43.5) 55 (45.1)
Charnley class
A and B 45 (26.0 to 47.5) 150 (77.7)
C 41 (37.0 to 43.5) 177 (54.8)
SF-36 PCS
< 50 43 (37.5 to 44.7) 287 (64.8)
≥ 50 47 (34.0 to 48.0) 94 (90.0)
SF-36 MCS
< 50 38 (28.7 to 41.5) 94 (54.0)
≥ 50 45 (40.7 to 46.5) 156 (48.3)
* BMI, body mass index; SF-36 P-/MCS, Short-Form 36 Physical/Mental
Component Summary
Table III. Patient acceptable symptom state (PASS) score thresholds for
mid-term follow-up Oxford knee score and proportion of patients classi-
fied as reaching a satisfactory symptom state (CI, confidence interval)
Parameter*
Threshold value 
(95% CI)
Satisfactory symptom
state (n, %)
Entire population 37 (31.8 to 38.5) 271 (73.8)
Follow-up
< 3 years 34 (29.7 to 37.5) 144 (78.7)
≥ 3 years 38 (32.5 to 41.5) 131 (74.0)
Gender
Males 39 (33.5 to 44.4) 89 (73.6)
Females 33 (30.5 to 37.5) 171 (70.7)
Age
< 70 years 34 (29.7 to 38.1) 139 (77.7)
≥ 70 years 38 (31.3 to 41.7) 140 (77.3)
BMI
< 30 kg/m2 38 (32.0 to 39.5) 170 (78.7)
≥ 30 kg/m2 35 (29.7 to 40.5) 84 (64.6)
Charnley class
A and B 39 (30.8 to 45.5) 53 (62.4)
C 36 (30.5 to 38.5) 180 (67.4)
SF-36 PCS
< 50 35 (31.3 to 38.5) 172 (63.2)
≥ 50 39 (25.0 to 47.0) 23 (39.0)
SF-36 MCS
< 50 33 (21.5 to 38.5) 108 (86.4)
≥ 50 38 (33.5 to 42.3) 147 (71.4)
* BMI, body mass index; SF-36 P-/MCS, Short-Form 36 Physical/Mental
Component Summary
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methodological difficulties are encountered both in
MCIDs and PASSs: both approaches lead to a loss of
power compared with the population-level mean differ-
ence, both approaches depend on population and con-
textual characteristics and there is no clear consensus on
the optimal statistical approach.8,10,39 Despite these diffi-
culties, MCIDs and PASSs are the best tools available to
analyse PROM data at the individual level.
In this study, we estimated PASS in OHS/OKS at mid-
term follow-up in a Dutch population. We found evi-
dence suggesting that PASSs are time-dependent. Besides
being time-dependent, PASS might also be population-
dependent, as different sub-groups had different PASS
thresholds. Without any form of external validation at a
similar follow-up period, we would advise against using
these PASS thresholds as absolute thresholds in defining
whether or not a patient has attained an acceptable
symptom state after THR/TKR.
Supplementary material
Two figures describing the relationship between
Oxford Score and numerical rating scale, and two
tables detailing response to Oxford Score by centre for
both operations, are available alongside this article. 
References
1. Keurentjes JC, Fiocco M, Schreurs BW, et al. Revision surgery is overestimated
in hip replacement. Bone Joint Res 2012;1:258–262.
2. Nouta KA, Pijls BG, Fiocco M, Keurentjes JC, Nelissen RG. How to deal with
lost to follow-up in total knee arthroplasty: a new method based on the competing
risks approach. Int Orthop 2013:Epub.
3. Arden NK, Kiran A, Judge A, et al. What is a good patient reported outcome after
total hip replacement? Osteoarthritis Cartilage 2011;19:155–162.
4. Ethgen O, Bruyère O, Richy F, Dardennes C, Reginster JY. Health-related qual-
ity of life in total hip and total knee arthroplasty: a qualitative and systematic review
of the literature. J Bone Joint Surg [Am] 2004;86-A:963–974.
5. Beswick AD, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion
of patients report long-term pain after total hip or knee replacement for osteoarthri-
tis?: a systematic review of prospective studies in unselected patients. BMJ Open
2012;2:000435.
6. Nilsdotter AK, Toksvig-Larsen S, Roos EM. Knee arthroplasty: are patients’
expectations fulfilled?: a prospective study of pain and function in 102 patients with
5-year follow-up. Acta Orthop 2009;80:55–61.
7. Scott CE, Bugler KE, Clement ND, et al. Patient expectations of arthroplasty of the
hip and knee. J Bone Joint Surg [Br] 2002;94-B:974–981.
8. Tubach F, Wells GA, Ravaud P, Dougados M. Minimal clinically important differ-
ence, low disease activity state, and patient acceptable symptom state: methodolog-
ical issues. J Rheumatol 2005;32:2025–2029.
9. Tubach F, Ravaud P, Baron G, et al. Evaluation of clinically relevant states in
patient reported outcomes in knee and hip osteoarthritis: the patient acceptable
symptom state. Ann Rheum Dis 2005;64:34–37.
10. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining
responsiveness and minimally important differences for patient-reported outcomes. J
Clin Epidemiol 2008;61:102–109.
11. Singh J, Sloan JA, Johanson NA. Challenges with health-related quality of life
assessment in arthroplasty patients: problems and solutions. J Am Acad Orthop Surg
2010;18:72–82.
12. Dawson J, Fitzpatrick R, Carr A, Murray D. Questionnaire on the perceptions of
patients about total hip replacement. J Bone Joint Surg [Br] 1996;78-B:185–190.
13. Dawson J, Fitzpatrick R, Murray D, Carr A. Questionnaire on the perceptions of
patients about total knee replacement. J Bone Joint Surg [Br] 1998;80-B:63–69.
14. Judge A, Arden NK, Kiran A, et al. Interpretation of patient-reported outcomes for
hip and knee replacement surgery: identification of thresholds associated with satis-
faction with surgery. J Bone Joint Surg [Br] 2012;94-B:412–418.
15. Vissers MM, Bussmann JB, Verhaar JAN, et al. Recovery of physical functioning
after total hip arthroplasty: systematic review and meta-analysis of the literature.
Phys Ther 2011;91:615–629.
16. Keurentjes JC, Fiocco M, So-Osman C, et al. Patients with severe radiographic
osteoarthritis have a better prognosis in physical functioning after hip and knee
replacement: a cohort-study. PLoS One 2013;8:59500.
17. Keurentjes JC, Blane D, Bartley M, et al. Socio-economic position has no effect
on improvement in health-related quality of life and patient satisfaction in total hip
and knee replacement: a cohort study. PLoS One 2013;8:56785.
Table IV. Comparison of mean numerical rating scale (NRS) for satisfaction between responders and non-responders according to the Patient Accept-
able Symptom State (PASS) score thresholds for total hip (THR) and total knee replacement (TKR)
Mean NRS for satisfaction
Procedure Responders (95% CI)
Non-responders 
(95% CI)
Mean difference adjusted for
age and gender* (95% CI)
Mean difference adjusted for 
all potential confounders† (95% CI)
THR 9.28 (9.26 to 9.29) 7.26 (7.22 to 7.31) 1.89 (1.53 to 2.25) 1.87 (1.47 to 2.26)
TKR 9.04 (9.01 to 9.06) 6.78 (6.71 to 6.84) 2.89 (2.40 to 3.38) 2.96 (2.44 to 3.48)
* stratified by quartiles of follow-up length 
† adjusted for age, gender, body mass index, Charnley classiﬁcation, indication (osteoarthritis vs other), pre-operative, Short-Form 36 physical and
mental component summaries and stratified by quartiles of follow-up length
Table V. Comparison of willingness to undergo surgery again between responders and non-responders
according to the Patient Acceptable Symptom State (PASS) score thresholds for total hip (THR) and total knee
replacement (TKR). An odds ratio (OR) > 1 indicates a higher odds of willingness to undergo surgery again in
responders compared with non-responders (CI, confidence interval)
Procedure Crude OR (95% CI)
OR adjusted for age 
and gender* (95% CI)
OR adjusted for all potential
confounders† (95% CI)
THR 7.64 (4.09 to 15.3) 6.97 (3.51 to 13.8) 8.53 (3.80 to 19.1)
TKR 7.28 (3.85 to 14.3) 7.92 (3.79 to 16.6) 7.73 (2.84 to 21.0)
* stratified by quartiles of follow-up length 
† adjusted for age, gender, body mass index, Charnley classiﬁcation, indication (osteoarthritis vs other), pre-
operative Short-Form 36 physical and mental component summaries, and stratified by quartiles of follow-up
length
PATIENT ACCEPTABLE SYMPTOM STATES AFTER TOTAL HIP OR KNEE REPLACEMENT AT MID-TERM FOLLOW-UP 13
VOL. 3, No. 1, JANUARY 2014
18. Keurentjes JC, Fiocco M, Nelissen RG. Willingness to undergo surgery again vali-
dated clinically important differences in health-related quality of life after total hip
replacement or total knee replacement surgery. J Clin Epidemiol 2013:Epub.
19. Evangelou E, Kerkhof HJ, Styrkarsdottir U, et al. A meta-analysis of genome-wide
association studies identifies novel variants associated with osteoarthritis of the hip.
Ann Rheum Dis 2013:Epub. 
20. Keurentjes JC, Fiocco M, So-Osman C, et al. Hip and knee replacement patients
prefer pen-and-paper questionnaires Implications for future patient-reported outcome
measure studies. Bone Joint Res 2013;2:238–244.
21. Chesworth BM, Mahomed NN, Bourne RB, Davis AM. Willingness to go through
surgery again validated the WOMAC clinically important difference from THR/TKR sur-
gery. J Clin Epidemiol 2008;61:907–918.
22. Gosens T, Hoefnagels NH, de Vet RC, et al. The “Oxford Heup Score”: the transla-
tion and validation of a questionnaire into Dutch to evaluate the results of total hip
arthroplasty. Acta Orthop 2005;76:204–211.
23. Haverkamp D, Breugem SJM, Sierevelt IN, Blankevoort L, van Dijk CN. Trans-
lation and validation of the Dutch version of the Oxford 12-item knee questionnaire for
knee arthroplasty. Acta Orthop 2005;76:347–352.
24. Dunbar MJ, Robertsson O, Ryd L. What’s all that noise?: the effect of co-morbidity on
health outcome questionnaire results after knee arthroplasty. Acta Orthop Scand
2004;75:119–126.
25. Charnley J. The long-term results of low-friction arthroplasty of the hip performed as
a primary intervention. J Bone Joint Surg [Br] 1972;54-B:61–76.
26. Ware J. SF-36 health survey: manual and interpretation guide. Boston: The Health Insti-
tute New England Medical Center, 1993.
27. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the
Dutch language version of the SF-36 Health Survey in community and chronic disease
populations. J Clin Epidemiol 1998;51:1055–1068.
28. Keurentjes JC, Van Tol FR, Fiocco M, Schoones J, Nelissen R. Minimal clinically
important differences in health-related quality of life after total hip or knee replacement:
a systematic review. Bone Joint Res 2012;1:71–77.
29. Baker PN, van der Meulen JH, Lewsey J, Gregg PJ. The role of pain and function
in determining patient satisfaction after total knee replacement: data from the National
Joint Registry for England and Wales. J Bone Joint Surg [Br] 2007;89-B:893–900.
30. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of
changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
Pain 2001;94:149–158.
31. No authors listed. R: A language and environment for statistical computing. Vienna: R
Foundation for Statistical Computing, 2008.
32. Judge A, Arden NK, Price A, et al. Assessing patients for joint replacement: can pre-
operative Oxford hip and knee scores be used to predict patient satisfaction following
joint replacement surgery and to guide patient selection? J Bone Joint Surg [Br]
2011;93-B:1660–1664.
33. Ng CY, Ballantyne JA, Brenkel IJ. Quality of life and functional outcome after pri-
mary total hip replacement: a five-year follow-up. J Bone Joint Surg [Br] 2007;89-
B:868–873.
34. Kvien TK, Heiberg T, Hagen Kr B. Minimal clinically important improvement/dif-
ference (MCII/MCID) and patient acceptable symptom state (PASS): what do these
concepts mean? Ann Rheum Dis 2007;66(Suppl 3):40–41.
35. Clement ND, Macdonald D, Simpson AH. The minimal clinically important differ-
ence in the Oxford knee score and Short Form 12 score after total knee arthroplasty.
Knee Surg Sports Traumatol Arthrosc 2013:Epub.
36. Paulsen A, Roos EM, Pedersen AB, Overgaard S. Minimal clinically important
improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthro-
plasty (THA) patients 1 year postoperatively. Acta Orthop 2013:Epub.
37. Browne JP, van der Meulen JH, Lewsey JD, Lamping DL, Black N. Mathemat-
ical coupling may account for the association between baseline severity and mini-
mally important difference values . J Clin Epidemiol 2010;63:865–874.
38. Dougados M. It’s good to feel better but it’s better to feel good. J Rheumatol
2005;32:1–2.
39. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the
minimal clinically important difference. Control Clin Trials 1989;10:407–415.
Funding statement:
 Ongoing research grant of the Dutch Arthritis Association to Professor R. G. H. H Nelis-
sen, Department of Orthopaedic Surgery, Leiden University Medical Center: grant
number LLP-013 (http://www.reumafonds.nl/informatie-voor-doelgroepen/profes-
sionals/ongoing-research). The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Author contributions:
 J. C. Keurentjes: Study conception and design, Data collection, Data analysis, Drafting
of the article
 F. R. Van Tol: Data collection, Drafting of the article, Critical revision of the article
 M. Fiocco: Study conception and design, Data analysis, Critical revision of the article
 C. So-Osman: Study conception and design, Data collection, Drafting of the article,
Critical revision of the article
 R. Onstenk: Data collection, Drafting of the article, Critical revision of the article
 A. W. M. M. Koopman-Van Gemert: Data collection, Drafting of the article, Critical revi-
sion of the article
 R. G. Pöll: Data collection, Drafting of the article, Critical revision of the article
 R. G. H. H. Nelissen: Study conception and design, Data collection, Drafting of the arti-
cle, Critical revision of the article
ICMJE Conflict of Interest:
 None declared
©2014 The British Editorial Society of Bone & Joint Surgery. This is an open-access arti-
cle distributed under the terms of the Creative Commons Attributions licence, which per-
mits unrestricted use, distribution, and reproduction in any medium, but not for
commercial gain, provided the original author and source are credited.
